Antisense RNA down-regulation of bcl-xL expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents

Cancer Research

Volumn 62, Issue 7, 2002, Pages 2175-2183

  Vilenchik, Maria ^a   Raffo, Anthony J ^a   Benimetskaya, Luba ^a   Shames, David ^a   Stein, C A ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CARBOPLATIN; COMPLEMENTARY RNA; CYTOTOXIC AGENT; DOCETAXEL; ETOPOSIDE; MITOXANTRONE; PROTEIN BCL XL; VINBLASTINE;

APOPTOSIS; ARTICLE; ARTIFICIAL MEMBRANE; CANCER CELL; CELL PROLIFERATION; ENDOPLASMIC RETICULUM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; MOLECULAR CLONING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-X PROTEIN; CELL DIVISION; DNA, NEOPLASM; DOWN-REGULATION; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; MALE; PLOIDIES; PROSTATIC NEOPLASMS; PROTEIN BIOSYNTHESIS; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, ANTISENSE; TRANSFECTION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 0036531791     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
2. Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells
3. Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types
4. Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2
5. Induction of apoptosis in fibroblasts by IL-1 β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3
6. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death
7. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo
8. Mitochondrial control of nuclear apoptosis [see comments]
9. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
10. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species
11. Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production
12. 2-fluxes
13. Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange
14. Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms
15. Mitochondria and apoptosis
16. Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex
17. Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities
18. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents
19. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells
20. Expression of bcl-xL can confer a multidrug resistance phenotype
21. Bcl-XL, and Bcl-2 repress a common pathway of cell death
22. Bcl-2 and the regulation of programmed cell death
23. Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis
24. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo
25. Bcl-xL in prostate cancer cells: Effects of overexpression and down-regulation on chemosensitivity
26. Chemosensitization of bladder carcinoma cells by bcl-xL antisense oligonucleotides
27. The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides
28. Two problems in antisense biotechnology: In vitro delivery and the design of antisense experiments
29. Inhibition of thymadine kinase gene expression by anti-sense RNA: A molecular approach to genetic analysis
30. Inhibition of oncogene expression using vector-generated RNA antisense
31. Is irrelevant cleavage the price of antisense efficacy?
32. X-linked IAP is a direct inhibitor of cell-death proteases
33. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
34. The inhibitors of apoptosis (IAPs) and their emerging role in cancer
35. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
36. Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival
37. Nonrandom chromosome abnormalities in testicular and ovarian germ cell tumor cell lines
38. Antisense oligonucleotides as therapeutic agents-is the bullet really magical?
39. IL-2 addiction: Withdrawal of growth factor activates a suicide program in dependent T cells
40. Application of the MTT assay to human prostate cancer cell lines in vitro: Establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects
41. Antimessenger oligodeoxyribonucleotides: An alternative to antisense RNA for artificial regulation of gene expression-A review
42. Role of Bcl-2 in the brain-derived neurotrophic factor survival response
43. Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemic HL60 cells
44. Antisense bcl-2 retrovirus vector increases the sensitivity of a human gastric adenocarcinoma cell line to photodynamic therapy
45. The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-x(L)
46. Bcl-2 regulates chondrocyte morphology and aggrecan gene expression independent of caspase activation and full apoptosis
47. The relationship between BcI2, Bax and p53: Consequences for cell cycle progression and cell death
48. Role of BCL-2 and cell cycle regulatory proteins for corticosensitivity assessment in childhood acute lymphoblastic leukaemia
49. Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage
50. Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival
51. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry
52. Bcl-xL blocks activation of related adhesion focal tyrosine kinase/proline-rich tyrosine kinase 2 and stress-activated protein kinase/c-Jun N-terminal protein kinase in the cellular response to methylmethane sulfonate
53. Prognostic significance of DNA ploidy in carcinoma of prostate
54. Flow cytometry of prostate cancer: Relationship of DNA content to survival
55. p53 oncogene mutations in human prostate cancer specimens
56. Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli
57. IAP family proteins-suppressors of apoptosis
58. Inhibitor of apoptosis (IAPS) proteins are up-regulated in early stage prostate cancer and predicts metastatic relapse
59. Cytokine induced expression of porcine inhibitor of apoptosis protein (IAP) family member is regulated by NF-κB
60. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control
61. Nuclear factor (NF)-κB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis
62. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells
63. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli